November 24, 2020 : Issue #1083

DISASTERS AVERTED — Near Miss Case Studies

Using Pens – Keep It In and Hold It Down!

TOP STORIES — Diabetes News and Research

Heart Failure in T2DM: Ready for Prime Time?

COVID-19 Severity Perceived in Recently Diagnosed Diabetes Patients

PRE-D Trial: Effect of Metformin, Dapagliflozin, or Exercise on Prediabetes Outcomes

MOST POPULAR ARTICLES OF THE MONTH

#1 Impact of Physical Activity and Metformin on Postprandial Glucose

#2 Role of Magnesium in Type 2 Diabetes and Stroke

#3 Empagliflozin Outcome on Obstructive Sleep Apnea, Cardiovascular, and Renal Events

Is sooner always better? As the years have gone by, many providers have looked to treat pre-diabetes in the same way as diabetes, with the idea of preventing the onset. Food choices and exercise have always been the number 1 choice, but as newer medications come on line and offer additional health benefits, the starting points are changing. This has been dictated by numerous studies and mostly logical thought processes.

This week our University of Colorado intern, Abdullah Al-Ajmi, PharmD Candidate, has an excellent feature to help you make the right decision for each individual patient.

*****************************

We can make a difference!

*****************************

Dave Joffe

Editor-in-chief

Susan received a phone call from her clinician’s office recommending that she start using a pen for her insulin.
She had also been prescribed a GLP-1 receptor agonist and was to go to the pharmacy to pick them up.

She went and signed up for the long ‘discourse’ patients receive when they pick up new meds including questions such as whether or not the pharmacist had offered instructions and pages of small print. She, like many of our patients, signed the sheets and went on her own way without ever talking to a pharmacist or asking a question.

Although not the most prevalent comorbid condition in patients with T2DM, heart failure was the most fatal in a 17-year long nationwide real-life cohort study. 

Newly-diagnosed diabetes and admission hyperglycemia are linked to rapid respiratory deterioration in COVID-19 patients. 

Multiple treatments were compared to improve outcomes in patients with prediabetes.